GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 02, 2019. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 02, 2019

We hereby submit the revised scrutinizer��s report in relation to the business transacted through (i) postal ballot; (ii) e-voting process; and (iii) polling paper at the venue of the meeting of the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (��Company��) convened and held on Saturday, June 1, 2019 at 12:00 Noon at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha �� 147201, Punjab pursuant to an order dated April 12, 2019 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Hon��ble Chandigarh bench of the National Company L

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on Jun 01, 2019. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2019Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigarh Bench of the Hon'ble National Company Law Tribunal at Chandigarh ("Tribunal"), a meeting of the equity shareholders of GlaxoSmithKline Consumer Healthca

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2019 - Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigarh Bench of the Hon'ble National Company Law Tribunal at Chandigarh ("Tribunal"), a meeting of the equity shareholders of GlaxoSmithKline Consumer Healt

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

In pursuance to Regulation 44 of per SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (��LODR��) and in furtherance to our letter dated August 8, 2018, we would like to inform you that we have received the Scrutinizers�� Report containing the consolidated results of the remote e-votes received upto the August 7, 2018 (5:00 P.M.) and the voting through ballot paper received till the conclusion of the Annual General Meeting. The details of voting results, as per the Scrutinizers�� Report and as per SEBI LODR, are enclosed in the prescribed format as ��Annexure A��.Based on t

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 08, 2018. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 08, 2018

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 09, 2017. Further, the company has informed the Exchange regarding voting results.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding the proceeding of Annual General Meeting held on April 23, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskcons_proceeds_23042010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Notice of the Annual General Meeting to be held on April 23, 2010. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_AGMNot_16042010.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the members of the Company held on April 24, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSk_MINAGM_06052009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that at the Annual General Meeting held on April 24, 2009 all the items of business contained in the Notice of the Annual General Meeting of the Company were approved by the Members, Who: (1) Approved the audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2008 together with the Directors' Report and Auditors' Report thereon. (2) Approved final dividend of Rs.5.00 per equity share of Rs.10 each for the year ended December 31, 2008 and confirmed the Interim Dividend amounting to Rs.10.00 per equi

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the members of the Company held on April 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCON_Min_27052008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange outcome of the Annual General Meeting of the Company held on April 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxosmith_Pro_AGM_02052008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Forty Eighth Annual General Meeting of the members of the Company held on April 27, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKGlaxoHealthcare.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the AGM of the Members of the Company held on April 29, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the Minutes of the Proceedings of the AGM of the members of the Company held on April 29, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the members of the Company have approved through postal ballot the buy back of equity shares of Rs.10 each at a price not exceeding Rs.370 per equity share and for an amount not exceeding Rs.1,23,02.81 Lacs which constitutes 25% of the Paid up Equity Share Capital and Free Reserves of the Company as on December 31,2003. The details of the results of the postal ballot declared on January 20, 2005 is as follows: a) Total number of valid votes cast - 19259951; b)Votes in favor of the Resolution - 19123351 (99.29%); c) Vote